Skip to content

Clinical trials

Migraine Disorders trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Migraine Disorders Country / region: China Clear all

63 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20101
20131
20142
20152
20162
20174
20181
20192
20202
20218
20229
20237
20248
20257
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Unknown status14
Recruiting13
Not yet recruiting6
Active, not recruiting5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer6
Second Affiliated Hospital, Zhejiang University, School of Medicine6
Chinese Academy of Medical Sciences, Fuwai Hospital4
Beijing Tiantan Hospital3
First Affiliated Hospital Xi'an Jiaotong University3
Brise Pharmaceuticals Co., Ltd.2
Chengdu University of Traditional Chinese Medicine2
China National Center for Cardiovascular Diseases2
Chinese PLA General Hospital2
H. Lundbeck A/S2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Migraine Disorders63
Foramen Ovale, Patent12
Headache Disorders, Secondary6
Headache3
Headache Disorders3
Headache Disorders, Primary3
Migraine without Aura3
Tension-Type Headache3
Fibromyalgia2
Migraine with Aura2

Trials

Showing 51 to 63 of 63. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.